{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:20:13Z","timestamp":1782325213902,"version":"3.54.5"},"reference-count":204,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Medical University of Bia\u0142ystok","doi-asserted-by":"publisher","award":["B.SUB.23.108"],"award-info":[{"award-number":["B.SUB.23.108"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Sarcopenia is a chronic, progressive skeletal muscle disease characterised by low muscle strength and quantity or quality, leading to low physical performance. Patients with type 2 diabetes mellitus (T2DM) are more at risk of sarcopenia than euglycemic individuals. Because of several shared pathways between the two diseases, sarcopenia is also a risk factor for developing T2DM in older patients. Various biomarkers are under investigation as potentially valuable for sarcopenia diagnosis and treatment monitoring. Biomarkers related to sarcopenia can be divided into markers evaluating musculoskeletal status (biomarkers specific to muscle mass, markers of the neuromuscular junction, or myokines) and markers assuming causal factors (adipokines, hormones, and inflammatory markers). This paper reviews the current knowledge about how diabetes and T2DM complications affect potential sarcopenia biomarker concentrations. This review includes markers recently proposed by the expert group of the European Society for the Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) as those that may currently be useful in phase II and III clinical trials of sarcopenia: myostatin (MSTN); follistatin (FST); irisin; brain-derived neurotrophic factor (BDNF); procollagen type III N-terminal peptide (PIIINP; P3NP); sarcopenia index (serum creatinine to serum cystatin C ratio); adiponectin; leptin; insulin-like growth factor-1 (IGF-1); dehydroepiandrosterone sulphate (DHEAS); C-reactive protein (CRP); interleukin-6 (IL-6), and tumor necrosis factor \u03b1 (TNF-\u03b1). A better understanding of factors influencing these biomarkers\u2019 levels, including diabetes and diabetic complications, may lead to designing future studies and implementing results in clinical practice.<\/jats:p>","DOI":"10.3390\/jcm13041107","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T11:19:01Z","timestamp":1707995941000},"page":"1107","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Diabetes Mellitus Should Be Considered While Analysing Sarcopenia-Related Biomarkers"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2732-0982","authenticated-orcid":false,"given":"Justyna","family":"Rentflejsz","sequence":"first","affiliation":[{"name":"Doctoral School, Medical University of Bialystok, 15-089 Bialystok, Poland"},{"name":"Department of Geriatrics, Medical University of Bialystok, 15-471 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-5241","authenticated-orcid":false,"given":"Zyta Beata","family":"Wojszel","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Medical University of Bialystok, 15-471 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ageing\/afz046","article-title":"Sarcopenia: Revised European consensus on definition and diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcsm.13190","article-title":"Sarcopenia is associated with a greater risk of polypharmacy and number of medications: A systematic review and meta-analysis","volume":"14","author":"Prokopidis","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/jcsm.13243","article-title":"Sarcopenia and health-related quality of life: A systematic review and meta-analysis","volume":"14","author":"Beaudart","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jcsm.12411","article-title":"Sarcopenia and its association with falls and fractures in older adults: A systematic review and meta-analysis","volume":"10","author":"Yeung","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jcsm.12160","article-title":"Sarcopenia and physical independence in older adults: The independent and synergic role of muscle mass and muscle function","volume":"8","author":"Cyrino","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000517099","article-title":"Sarcopenia Is Associated with Mortality in Adults: A Systematic Review and Meta-Analysis","volume":"68","author":"Xu","year":"2022","journal-title":"Gerontology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jcsm.12783","article-title":"Global prevalence of sarcopenia and severe sarcopenia: A systematic review and meta-analysis","volume":"13","author":"Balntzi","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12603-019-1267-x","article-title":"Differences in the Prevalence of Sarcopenia in Community-Dwelling, Nursing Home and Hospitalized Individuals. A Systematic Review and Meta-Analysis","volume":"24","author":"Papadopoulou","year":"2020","journal-title":"J. Nutr. Health Aging"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Giovannini, S., Brau, F., Forino, R., Berti, A., D\u2019Ignazio, F., Loreti, C., Bellieni, A., D\u2019Angelo, E., Di Caro, F., and Biscotti, L. (2021). Sarcopenia: Diagnosis and Management, State of the Art and Contribution of Ultrasound. J. Clin. Med., 10.","DOI":"10.3390\/jcm10235552"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Baeyens","year":"2010","journal-title":"Age Ageing"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","article-title":"Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia","volume":"15","author":"Chen","year":"2014","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","article-title":"Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International working group on sarcopenia","volume":"12","author":"Fielding","year":"2011","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jamda.2011.04.014","article-title":"Sarcopenia with limited mobility: An international consensus","volume":"12","author":"Morley","year":"2011","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00223-022-01054-z","article-title":"Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Acad\u00e9mique de Recherche et d\u2019Exp\u00e9rimentation en Sant\u00e9 (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging","volume":"112","author":"Ladang","year":"2023","journal-title":"Calcif. Tissue Int."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Selleck, M.J., Senthil, M., and Wall, N.R. (2017). Making Meaningful Clinical Use of Biomarkers. Biomark. Insights, 12.","DOI":"10.1177\/1177271917715236"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00223-020-00742-y","article-title":"Type 2 Diabetes Mellitus is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-analysis","volume":"107","author":"Anagnostis","year":"2020","journal-title":"Calcif. Tissue Int."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Izzo, A., Massimino, E., Riccardi, G., and Della Pepa, G. (2021). A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors. Nutrients, 13.","DOI":"10.3390\/nu13010183"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"782391","DOI":"10.3389\/fendo.2021.782391","article-title":"The Association Between Diabetes Mellitus and Risk of Sarcopenia: Accumulated Evidences From Observational Studies","volume":"12","author":"Qiao","year":"2021","journal-title":"Front Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/jdi.13436","article-title":"High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study","volume":"12","author":"Mori","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"38937","DOI":"10.1038\/srep38937","article-title":"Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/1747-0080.12551","article-title":"Sarcopenia, nutritional status and type 2 diabetes mellitus: A cross-sectional study in a group of Mexican women residing in a nursing home","volume":"77","author":"Lazarevich","year":"2020","journal-title":"Nutr. Diet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13098-018-0326-5","article-title":"Sarcopenia: A chronic complication of type 2 diabetes mellitus","volume":"10","author":"Trierweiler","year":"2018","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2147\/DMSO.S237362","article-title":"Correlation Between Diabetic Peripheral Neuropathy and Sarcopenia in Patients with Type 2 Diabetes Mellitus and Diabetic Foot Disease: A Cross-Sectional Study","volume":"13","author":"Yang","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"104338","DOI":"10.1016\/j.archger.2021.104338","article-title":"Risk of sarcopenia among older persons with Type 2 diabetes mellitus with different status of albuminuria: A dose-responsive association","volume":"95","author":"Chang","year":"2021","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7841390","DOI":"10.1155\/2020\/7841390","article-title":"Sarcopenia in Type 2 Diabetes Mellitus: A Cross-Sectional Observational Study","volume":"2020","author":"Pechmann","year":"2020","journal-title":"Int. J. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13098-021-00707-7","article-title":"The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: A systematic review and meta-analysis","volume":"13","author":"Ai","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/jdi.13070","article-title":"Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus","volume":"10","author":"Sugimoto","year":"2019","journal-title":"J. Diabetes Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1111\/jdi.13882","article-title":"Poor glycemic control rather than types of diabetes is a risk factor for sarcopenia in diabetes mellitus: The MUSCLES-DM study","volume":"13","author":"Hiromine","year":"2022","journal-title":"J. Diabetes Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.12998\/wjcc.v9.i33.10064","article-title":"Effects of anti-diabetic drugs on sarcopenia: Best treatment options for elderly patients with type 2 diabetes mellitus and sarcopenia","volume":"9","author":"Ma","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ggi.12688","article-title":"Sarcopenia and frailty in older patients with diabetes mellitus","volume":"16","author":"Umegaki","year":"2016","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"107926","DOI":"10.1016\/j.jdiacomp.2021.107926","article-title":"Influence of glucose, insulin fluctuation, and glycosylated hemoglobin on the outcome of sarcopenia in patients with type 2 diabetes mellitus","volume":"35","author":"Lin","year":"2021","journal-title":"J. Diabetes Complicat."},{"key":"ref_34","first-page":"1912","article-title":"The association between glucose fluctuation with sarcopenia in elderly patients with type 2 diabetes mellitus","volume":"27","author":"Ma","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ogama, N., Sakurai, T., Kawashima, S., Tanikawa, T., Tokuda, H., Satake, S., Miura, H., Shimizu, A., Kokubo, M., and Niida, S. (2019). Association of Glucose Fluctuations with Sarcopenia in Older Adults with Type 2 Diabetes Mellitus. J. Clin. Med., 8.","DOI":"10.3390\/jcm8030319"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00223-015-9990-8","article-title":"Reduction in Endogenous Insulin Secretion is a Risk Factor of Sarcopenia in Men with Type 2 Diabetes Mellitus","volume":"97","author":"Tanaka","year":"2015","journal-title":"Calcif. Tissue Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1094075","DOI":"10.3389\/fendo.2023.1094075","article-title":"Association between body fat and sarcopenia in older adults with type 2 diabetes mellitus: A cross-sectional study","volume":"14","author":"Sun","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1109800","DOI":"10.3389\/fendo.2023.1109800","article-title":"A bi-directional Mendelian randomization study of sarcopenia-related traits and type 2 diabetes mellitus","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s41999-019-00230-z","article-title":"Sarcopenia and diabetes mellitus: Evidence for a bi-directional relationship","volume":"10","author":"Mesinovic","year":"2019","journal-title":"Eur. Geriatr. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s41999-019-00216-x","article-title":"Association between sarcopenia and diabetes: A systematic review and meta-analysis of observational studies","volume":"10","author":"Veronese","year":"2019","journal-title":"Eur. Geriatr. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/jdi.12392","article-title":"Difference between old and young adults in contribution of \u03b2-cell function and sarcopenia in developing diabetes mellitus","volume":"7","author":"Koo","year":"2016","journal-title":"J. Diabetes Investig."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Huang, S., Xiang, C., and Song, Y. (2022). Identification of the shared gene signatures and pathways between sarcopenia and type 2 diabetes mellitus. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0265221"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jamda.2013.05.004","article-title":"Sarcopenia and diabetes: Two sides of the same coin","volume":"14","author":"Landi","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"104437","DOI":"10.1016\/j.archger.2021.104437","article-title":"The vicious cycle in the development of diabetes mellitus and sarcopenia in older persons","volume":"95","author":"Chen","year":"2021","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1900\/RDS.2022.18.157","article-title":"Sarcopenia and Chronic Complications of Type 2 Diabetes Mellitus","volume":"18","author":"Purnamasari","year":"2022","journal-title":"Rev. Diabet. Stud."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1026070911202","article-title":"Searching for the exercise factor: Is IL-6 a candidate?","volume":"24","author":"Pedersen","year":"2003","journal-title":"J. Muscle Res. Cell Motil."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","article-title":"Muscle-Organ Crosstalk: The Emerging Roles of Myokines","volume":"41","author":"Severinsen","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1083722","DOI":"10.3389\/fendo.2023.1083722","article-title":"Alternative skeletal muscle index for sarcopenia diagnosis in elderly patients with type 2 diabetes mellitus: A pilot study","volume":"14","author":"Lu","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Picca, A., Calvani, R., Cesari, M., Landi, F., Bernabei, R., Coelho-J\u00fanior, H.J., and Marzetti, E. (2020). Biomarkers of Physical Frailty and Sarcopenia: Coming up to the Place?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165635"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s11357-020-00197-x","article-title":"Identification of biomarkers for physical frailty and sarcopenia through a new multi-marker approach: Results from the BIOSPHERE study","volume":"43","author":"Calvani","year":"2021","journal-title":"Geroscience"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8632","DOI":"10.1038\/s41598-021-87974-6","article-title":"Prediction of sarcopenia using a battery of circulating biomarkers","volume":"11","author":"Qaisar","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4026940","DOI":"10.1155\/2022\/4026940","article-title":"A Combination of Serum Biomarkers in Elderly Patients with Sarcopenia: A Cross-Sectional Observational Study","volume":"2022","author":"Ying","year":"2022","journal-title":"Int. J. Endocrinol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Mankhong, S., Kim, S., Moon, S., Kwak, H.B., Park, D.H., and Kang, J.H. (2020). Experimental Models of Sarcopenia: Bridging Molecular Mechanism and Therapeutic Strategy. Cells, 9.","DOI":"10.3390\/cells9061385"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Baczek, J., Silkiewicz, M., and Wojszel, Z.B. (2020). Myostatin as a Biomarker of Muscle Wasting and other Pathologies-State of the Art and Knowledge Gaps. Nutrients, 12.","DOI":"10.3390\/nu12082401"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s11596-012-0092-9","article-title":"Increased circulating myostatin in patients with type 2 diabetes mellitus","volume":"32","author":"Wang","year":"2012","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/17461391.2020.1762755","article-title":"Resistance training attenuates circulating FGF-21 and myostatin and improves insulin resistance in elderly men with and without type 2 diabetes mellitus: A randomised controlled clinical trial","volume":"21","author":"Shabkhiz","year":"2021","journal-title":"Eur. J. Sport Sci."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Du, Y., Xu, C., Shi, H., Jiang, X., Tang, W., Wu, X., Chen, M., Li, H., Zhang, X., and Cheng, Q. (2021). Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women. BMC Geriatr., 21.","DOI":"10.1186\/s12877-021-02481-7"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/dmrr.2415","article-title":"Plasma follistatin is elevated in patients with type 2 diabetes: Relationship to hyperglycemia, hyperinsulinemia, and systemic low-grade inflammation","volume":"29","author":"Hansen","year":"2013","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"dgaa090","DOI":"10.1210\/clinem\/dgaa090","article-title":"Circulating Follistatin and Activin A and Their Regulation by Insulin in Obesity and Type 2 Diabetes","volume":"105","author":"Sylow","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Alsaawi, T.A., Aldisi, D., Abulmeaty, M.M.A., Khattak, M.N.K., Alnaami, A.M., Sabico, S., and Al-Daghri, N.M. (2022). Screening for Sarcopenia among Elderly Arab Females: Influence of Body Composition, Lifestyle, Irisin, and Vitamin D. Nutrients, 14.","DOI":"10.3390\/nu14091855"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s41999-022-00635-3","article-title":"The relationship between sarcopenia detected in newly diagnosed colorectal cancer patients and FGF21, irisin and CRP levels","volume":"13","author":"Oflazoglu","year":"2022","journal-title":"Eur. Geriatr. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"16093","DOI":"10.1038\/s41598-020-73176-z","article-title":"Association between serum irisin concentrations and sarcopenia in patients with liver cirrhosis: A cross-sectional study","volume":"10","author":"Zhao","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12020-018-1814-y","article-title":"The novel myokine irisin: Clinical implications and potential role as a biomarker for sarcopenia in postmenopausal women","volume":"64","author":"Park","year":"2019","journal-title":"Endocrine"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/ggi.13030","article-title":"Circulating irisin levels as a predictive biomarker for sarcopenia: A cross-sectional community-based study","volume":"17","author":"Chang","year":"2017","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e26529","DOI":"10.1097\/MD.0000000000026529","article-title":"Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus: A cross-sectional study","volume":"100","author":"Oguz","year":"2021","journal-title":"Medcine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1055\/s-0042-108730","article-title":"Lower Circulating Irisin Level in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis","volume":"48","author":"Du","year":"2016","journal-title":"Horm. Metab. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"108788","DOI":"10.1016\/j.diabres.2021.108788","article-title":"Lower levels of irisin in patients with type 2 diabetes mellitus: A meta-analysis","volume":"175","author":"Song","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ggi.14089","article-title":"Brain-derived neurotrophic factor is associated with sarcopenia and frailty in Japanese hemodialysis patients","volume":"21","author":"Miyazaki","year":"2021","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.transproceed.2021.04.021","article-title":"Serum Brain-Derived Neurotrophic Factor and Myostatin Levels Are Associated With Skeletal Muscle Mass in Kidney Transplant Recipients","volume":"53","author":"Koito","year":"2021","journal-title":"Transplant. Proc."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Moosaie, F., Mohammadi, S., Saghazadeh, A., Dehghani Firouzabadi, F., and Rezaei, N. (2023). Brain-derived neurotrophic factor in diabetes mellitus: A systematic review and meta-analysis. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0268816"},{"key":"ref_72","first-page":"129","article-title":"Procollagen type III N-terminal peptide (P3NP) and lean mass: A cross-sectional study","volume":"2","author":"Berry","year":"2013","journal-title":"J. Frailty Aging"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Chen, Y.Y., Chiu, Y.L., Kao, T.W., Peng, T.C., Yang, H.F., and Chen, W.L. (2021). Cross-sectional associations among P3NP, HtrA, Hsp70, Apelin and sarcopenia in Taiwanese population. BMC Geriatr., 21.","DOI":"10.1186\/s12877-021-02146-5"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ahj.2007.04.006","article-title":"Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community","volume":"154","author":"Wang","year":"2007","journal-title":"Am. Heart J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/CIA.S351068","article-title":"Sarcopenia Index Based on Serum Creatinine and Cystatin C is Associated with Mortality, Nutritional Risk\/Malnutrition and Sarcopenia in Older Patients","volume":"17","author":"Ren","year":"2022","journal-title":"Clin. Interv. Aging"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Ge, J., Zeng, J., Ma, H., Sun, S., Zhao, Z., Jing, Y., Qian, C., Fei, Z., Cui, R., and Qu, S. (2022). A New Index Based on Serum Creatinine and Cystatin C Can Predict the Risks of Sarcopenia, Falls and Fractures in Old Patients with Low Bone Mineral Density. Nutrients, 14.","DOI":"10.3390\/nu14235020"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4093\/dmj.2021.0074","article-title":"Normalized Creatinine-to-Cystatin C Ratio and Risk of Diabetes in Middle-Aged and Older Adults: The China Health and Retirement Longitudinal Study","volume":"46","author":"Qiu","year":"2022","journal-title":"Diabetes Metab. J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"576619","DOI":"10.3389\/fendo.2021.576619","article-title":"Adiponectin and Sarcopenia: A Systematic Review With Meta-Analysis","volume":"12","author":"Komici","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1590\/2359-3997000000316","article-title":"Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: A literature review","volume":"61","author":"Frankenberg","year":"2017","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/gerona\/63.5.536","article-title":"Altered growth hormone, cortisol, and leptin secretion in healthy elderly persons with sarcopenia and mixed body composition phenotypes","volume":"63","author":"Waters","year":"2008","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/jcsm.12417","article-title":"Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention","volume":"10","author":"Li","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_82","first-page":"1715","article-title":"Negative correlation between leptin serum levels and sarcopenia in hemodialysis patients","volume":"11","author":"Lin","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.2147\/JIR.S335694","article-title":"Higher Serum Leptin Levels are Associated with a Reduced Risk of Sarcopenia but a Higher Risk of Dynapenia Among Older Adults","volume":"14","author":"Kao","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Szekeres, Z., Sandor, B., Bognar, Z., Ramadan, F.H.J., Palfi, A., Bodis, B., Toth, K., and Szabados, E. (2023). Clinical Study of Metabolic Parameters, Leptin and the SGLT2 Inhibitor Empagliflozin among Patients with Obesity and Type 2 Diabetes. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054405"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"300060519870407","DOI":"10.1177\/0300060519870407","article-title":"Relationships among resistin, adiponectin, and leptin and microvascular complications in patients with type 2 diabetes mellitus","volume":"48","author":"Wang","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/ijem.IJEM_491_15","article-title":"Correlation of Serum Adiponectin and Leptin levels in Obesity and Type 2 Diabetes Mellitus","volume":"22","author":"Diwan","year":"2018","journal-title":"Indian. J. Endocrinol. Metab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1758-5996-6-99","article-title":"Association of adipokines, leptin\/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus","volume":"6","year":"2014","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Bian, A., Ma, Y., Zhou, X., Guo, Y., Wang, W., Zhang, Y., and Wang, X. (2020). Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly. BMC Musculoskelet. Disord., 21.","DOI":"10.1186\/s12891-020-03236-y"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Saeki, C., Kanai, T., Nakano, M., Oikawa, T., Torisu, Y., Saruta, M., and Tsubota, A. (2020). Low Serum Branched-Chain Amino Acid and Insulin-Like Growth Factor-1 Levels Are Associated with Sarcopenia and Slow Gait Speed in Patients with Liver Cirrhosis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9103239"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"108998","DOI":"10.1016\/j.diabres.2021.108998","article-title":"A low serum IGF-1 is correlated with sarcopenia in subjects with type 1 diabetes mellitus: Findings from a post-hoc analysis of the iDIAMOND study","volume":"179","author":"Hata","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1327332","DOI":"10.1155\/2022\/1327332","article-title":"Association between Sarcopenia and Insulin-Like Growth Factor-1, Myostatin, and Insulin Resistance in Elderly Patients Undergoing Hemodialysis","volume":"2022","author":"Widajanti","year":"2022","journal-title":"J. Aging Res."},{"key":"ref_92","first-page":"2017.e2011","article-title":"Biomarkers Profile of People With Sarcopenia: A Cross-sectional Analysis From UK Biobank","volume":"21","author":"Gray","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/000331970605700306","article-title":"Total serum insulin-like growth factor-1 and C-reactive protein in metabolic syndrome with or without diabetes","volume":"57","author":"Efstratiadis","year":"2006","journal-title":"Angiology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e25432","DOI":"10.1097\/MD.0000000000025432","article-title":"Correlation analysis of IGF-1, ZAG, nesfatin-1, HbA1c levels, and type 2 diabetes mellitus complicated with hypothyroidism","volume":"100","author":"He","year":"2021","journal-title":"Medcine"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/aje\/kwv188","article-title":"Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study","volume":"183","author":"Drogan","year":"2016","journal-title":"Am. J. Epidemiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2337\/dc10-0770","article-title":"Association between serum IGF-1 and diabetes among U.S. adults","volume":"33","author":"Teppala","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1925424","DOI":"10.1155\/2016\/1925424","article-title":"Levels of Serum 25(OH)VD3, HIF-1\u03b1, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio","volume":"2016","author":"Shao","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/gerona\/59.5.M466","article-title":"Effect of DHEAS on skeletal muscle over the life span: The InCHIANTI study","volume":"59","author":"Valenti","year":"2004","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/rej.2013.1442","article-title":"Association of androgen with skeletal muscle mass and muscle function among men and women aged 50 years and older in Taiwan: Results from the I-Lan longitudinal aging study","volume":"16","author":"Hwang","year":"2013","journal-title":"Rejuvenation Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00125-016-4136-8","article-title":"Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: The Rotterdam Study","volume":"60","author":"Brahimaj","year":"2017","journal-title":"Diabetologia"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/1753-0407.12322","article-title":"Combined effects of sex hormone-binding globulin and sex hormones on risk of incident type 2 diabetes","volume":"8","author":"Hu","year":"2016","journal-title":"J. Diabetes"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.metabol.2004.12.011","article-title":"Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population: The Funagata Study","volume":"54","author":"Kameda","year":"2005","journal-title":"Metabolism"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.maturitas.2016.11.006","article-title":"Inflammation and sarcopenia: A systematic review and meta-analysis","volume":"96","author":"Bano","year":"2017","journal-title":"Maturitas"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/dc12-0702","article-title":"Inflammatory markers and risk of type 2 diabetes: A systematic review and meta-analysis","volume":"36","author":"Wang","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cyto.2016.06.028","article-title":"Adiponectin, TNF-\u03b1 and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis","volume":"86","author":"Liu","year":"2016","journal-title":"Cytokine"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1249\/MSS.0b013e3182178bb4","article-title":"Expression and function of myostatin in obesity, diabetes, and exercise adaptation","volume":"43","author":"Allen","year":"2011","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Lee, E.J., Ahmad, S.S., Lim, J.H., Ahmad, K., Shaikh, S., Lee, Y.S., Park, S.J., Jin, J.O., Lee, Y.H., and Choi, I. (2021). Interaction of Fibromodulin and Myostatin to Regulate Skeletal Muscle Aging: An Opposite Regulation in Muscle Aging, Diabetes, and Intracellular Lipid Accumulation. Cells, 10.","DOI":"10.3390\/cells10082083"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"9878","DOI":"10.1038\/s41598-017-10404-z","article-title":"Inhibition of GDF8 (Myostatin) accelerates bone regeneration in diabetes mellitus type 2","volume":"7","author":"Wallner","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11248-020-00194-y","article-title":"Enhanced skeletal muscle growth in myostatin-deficient transgenic pigs had improved glucose uptake in stretozotocin-induced diabetes","volume":"29","author":"Li","year":"2020","journal-title":"Transgenic Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"32495","DOI":"10.1038\/srep32495","article-title":"Myostatin inhibition therapy for insulin-deficient type 1 diabetes","volume":"6","author":"Coleman","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.2337\/db11-0915","article-title":"Myostatin inhibition prevents diabetes and hyperphagia in a mouse model of lipodystrophy","volume":"61","author":"Guo","year":"2012","journal-title":"Diabetes"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cyto.2017.12.008","article-title":"Myostatin and adipokines: The role of the metabolically unhealthy obese phenotype in muscle function and aerobic capacity in young adults","volume":"107","author":"Carvalho","year":"2018","journal-title":"Cytokine"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12020-015-0758-8","article-title":"Relationship between myostatin and irisin in type 2 diabetes mellitus: A compensatory mechanism to an unfavourable metabolic state?","volume":"52","year":"2016","journal-title":"Endocrine"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"108382","DOI":"10.1016\/j.jdiacomp.2022.108382","article-title":"Correlation between lipoprotein(a), albuminuria, myostatin and sarcopenia in elderly patients with type 2 diabetes","volume":"37","author":"Li","year":"2023","journal-title":"J. Diabetes Complicat."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/13813455.2020.1829649","article-title":"The effect of two concurrent exercise modalities on serum concentrations of FGF21, irisin, follistatin, and myostatin in men with type 2 diabetes mellitus","volume":"129","author":"Bijeh","year":"2023","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"107592","DOI":"10.1016\/j.jdiacomp.2020.107592","article-title":"Serum myostatin levels are positively associated with diabetic retinopathy in individuals with type 2 diabetes mellitus","volume":"34","author":"Chung","year":"2020","journal-title":"J. Diabetes Complicat."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Brandt, C., Nielsen, A.R., Fischer, C.P., Hansen, J., Pedersen, B.K., and Plomgaard, P. (2012). Plasma and muscle myostatin in relation to type 2 diabetes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037236"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s42000-021-00317-y","article-title":"Myostatin serum levels in children with type 1 diabetes mellitus","volume":"20","author":"Efthymiadou","year":"2021","journal-title":"Hormones"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e14500","DOI":"10.14814\/phy2.14500","article-title":"Muscle and serum myostatin expression in type 1 diabetes","volume":"8","author":"Dial","year":"2020","journal-title":"Physiol. Rep."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1018779","DOI":"10.3389\/fendo.2023.1018779","article-title":"Cord blood myostatin concentrations by gestational diabetes mellitus and fetal sex","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2014.11.006","article-title":"Myostatin in the placentae of pregnancies complicated with gestational diabetes mellitus","volume":"36","author":"Peiris","year":"2015","journal-title":"Placenta"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3350\/cmh.2020.0005","article-title":"The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma","volume":"26","author":"Choi","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.exger.2015.02.008","article-title":"Serum concentrations of insulin-like growth factor-1, members of the TGF-beta superfamily and follistatin do not reflect different stages of dynapenia and sarcopenia in elderly women","volume":"64","author":"Hofmann","year":"2015","journal-title":"Exp. Gerontol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/ijpvm.IJPVM_310_17","article-title":"Skeletal Muscle Hypertrophy, Insulin-like Growth Factor 1, Myostatin and Follistatin in Healthy and Sarcopenic Elderly Men: The Effect of Whole-body Resistance Training","volume":"10","author":"Negaresh","year":"2019","journal-title":"Int. J. Prev. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1096\/fj.201802059RRR","article-title":"Intravascular Follistatin gene delivery improves glycemic control in a mouse model of type 2 diabetes","volume":"34","author":"Davey","year":"2020","journal-title":"FASEB J."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.1038\/s41467-021-26536-w","article-title":"Elevated circulating follistatin associates with an increased risk of type 2 diabetes","volume":"12","author":"Wu","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2016-1681","article-title":"Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes","volume":"101","author":"Hansen","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"111744","DOI":"10.1016\/j.exger.2022.111744","article-title":"Serum irisin level is independent of sarcopenia and related muscle parameters in older adults","volume":"162","author":"Baek","year":"2022","journal-title":"Exp. Gerontol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1210\/jc.2014-1195","article-title":"Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans","volume":"99","author":"Choi","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"AlKhairi, I., Cherian, P., Abu-Farha, M., Madhoun, A.A., Nizam, R., Melhem, M., Jamal, M., Al-Sabah, S., Ali, H., and Tuomilehto, J. (2019). Increased Expression of Meteorin-Like Hormone in Type 2 Diabetes and Obesity and Its Association with Irisin. Cells, 8.","DOI":"10.3390\/cells8101283"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1002\/edm2.403","article-title":"Evaluation of serum levels of Irisin as a marker of endothelial dysfunction in patients with type 2 diabetes mellitus","volume":"6","author":"Ahmed","year":"2023","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.15537\/smj.2020.12.25461","article-title":"Evaluation of irisin, retinol-binding protein 4, and leptin serum levels as biomarkers of macrovascular complications involvement in Saudi type 2 diabetes mellitus. A case-control study","volume":"41","author":"Ali","year":"2020","journal-title":"Saudi Med. J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.dsx.2018.04.025","article-title":"Novel adipokines vaspin and irisin as risk biomarkers for cardiovascular diseases in type 2 diabetes mellitus","volume":"12","author":"Ibrahim","year":"2018","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Berezin, A.A., Lichtenauer, M., Boxhammer, E., St\u00f6hr, E., and Berezin, A.E. (2022). Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus. Cells, 11.","DOI":"10.3390\/cells11182794"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Berezin, A.A., Obradovic, A.B., Fushtey, I.M., Berezina, T.A., Lichtenauer, M., and Berezin, A.E. (2023). Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10040136"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/a-1475-4444","article-title":"Association Between Serum Irisin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis","volume":"53","author":"Wang","year":"2021","journal-title":"Horm. Metab. Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s13300-021-01023-z","article-title":"Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus","volume":"12","author":"Wang","year":"2021","journal-title":"Diabetes Ther."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s11357-021-00510-2","article-title":"A neuromuscular perspective of sarcopenia pathogenesis: Deciphering the signaling pathways involved","volume":"44","author":"Ferreira","year":"2022","journal-title":"Geroscience"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"10367","DOI":"10.1038\/s41598-023-37229-3","article-title":"Inflammatory biomarkers at different stages of Sarcopenia in older women","volume":"13","author":"Avelar","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Karim, A., Muhammad, T., and Qaisar, R. (2021). Prediction of Sarcopenia Using Multiple Biomarkers of Neuromuscular Junction Degeneration in Chronic Obstructive Pulmonary Disease. J. Pers. Med., 11.","DOI":"10.3390\/jpm11090919"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s12031-022-01970-7","article-title":"Evaluation of Sarcopenia Using Biomarkers of the Neuromuscular Junction in Parkinson\u2019s Disease","volume":"72","author":"Karim","year":"2022","journal-title":"J. Mol. Neurosci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s11357-023-00894-3","article-title":"Muscle quality, physical performance, and comorbidity are predicted by circulating procollagen type III N-terminal peptide (P3NP): The InCHIANTI follow-up study","volume":"46","author":"Pellegrino","year":"2023","journal-title":"Geroscience"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"111523","DOI":"10.1016\/j.exger.2021.111523","article-title":"Association between plasma procollagen type III N-terminal peptide (P3NP) levels and physical performance in elderly men: The Korean Frailty and Aging Cohort Study (KFACS)","volume":"154","author":"Shin","year":"2021","journal-title":"Exp. Gerontol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13539-011-0021-y","article-title":"Evaluation of early biomarkers of muscle anabolic response to testosterone","volume":"2","author":"Chen","year":"2011","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1210\/jc.2009-1434","article-title":"N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosterone","volume":"94","author":"Bhasin","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e2998","DOI":"10.1002\/dmrr.2998","article-title":"Procollagen-III peptide identifies adipose tissue-associated inflammation in type 2 diabetes with or without nonalcoholic liver disease","volume":"34","author":"Barchetta","year":"2018","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1464-5491.2001.00576.x","article-title":"Biochemical markers of type III and I collagen: Association with retinopathy and neuropathy in type 1 diabetic subjects","volume":"18","author":"Arkkila","year":"2001","journal-title":"Diabet. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0168-8227(94)90102-3","article-title":"Serum levels of type III procollagen peptide and peripheral vascular disease in diabetic patients","volume":"23","author":"Migdalis","year":"1994","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/CCM.0000000000002013","article-title":"Evaluating Muscle Mass by Using Markers of Kidney Function: Development of the Sarcopenia Index","volume":"45","author":"Kashani","year":"2017","journal-title":"Crit. Care Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e13182","DOI":"10.1111\/ctr.13182","article-title":"The sarcopenia index: A novel measure of muscle mass in lung transplant candidates","volume":"32","author":"Kashani","year":"2018","journal-title":"Clin. Transplant."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.clnu.2018.05.031","article-title":"Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers","volume":"38","author":"Barreto","year":"2019","journal-title":"Clin. Nutr."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.clnu.2020.08.010","article-title":"Serum creatinine\/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease","volume":"40","author":"Hirai","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41598-020-58304-z","article-title":"Sarcopenia index based on serum creatinine and cystatin C is associated with 3-year mortality in hospitalized older patients","volume":"10","author":"Tang","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"11534","DOI":"10.1038\/s41598-018-29808-6","article-title":"A sarcopenia index based on serum creatinine and cystatin C cannot accurately detect either low muscle mass or sarcopenia in urban community-dwelling older people","volume":"8","author":"He","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s41999-019-00197-x","article-title":"Serum creatinine and cystatin C-based index can be a screening biomarker for sarcopenia in older population","volume":"10","author":"Singhal","year":"2019","journal-title":"Eur. Geriatr. Med."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.diabres.2018.02.025","article-title":"Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes","volume":"139","author":"Osaka","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.numecd.2022.02.005","article-title":"Low serum creatinine to cystatin C ratio is independently associated with sarcopenia and high carotid plaque score in patients with type 2 diabetes","volume":"32","author":"Shin","year":"2022","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"e002910","DOI":"10.1136\/bmjdrc-2022-002910","article-title":"Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes","volume":"10","author":"Hashimoto","year":"2022","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.diabres.2018.10.021","article-title":"The serum creatinine to cystatin C ratio predicts bone fracture in patients with type 2 diabetes: The Fukuoka Diabetes Registry","volume":"146","author":"Komorita","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Dai, H., and Xu, J. (2022). Creatinine-to-cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus. BMC Musculoskelet. Disord., 23.","DOI":"10.1186\/s12891-022-05636-8"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13098-022-00958-y","article-title":"Prognostic value of creatinine-to-cystatin c ratio in patients with type 2 diabetes mellitus: A cohort study","volume":"14","author":"Wei","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/ijpvm.IJPVM_193_20","article-title":"Adiponectin: Role in Physiology and Pathophysiology","volume":"11","author":"Nguyen","year":"2020","journal-title":"Int. J. Prev. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1210\/jc.2004-1980","article-title":"Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics","volume":"90","author":"Chen","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1210\/en.2006-0251","article-title":"Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling","volume":"147","author":"Wang","year":"2006","journal-title":"Endocrinology"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jacc.2020.11.069","article-title":"Leptin in Leanness and Obesity: JACC State-of-the-Art Review","volume":"77","author":"Perakakis","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.jrn.2022.05.003","article-title":"Sarcopenic Obesity Versus Nonobese Sarcopenia in Hemodialysis Patients: Differences in Nutritional Status, Quality of Life, and Clinical Outcomes","volume":"33","author":"Beberashvili","year":"2023","journal-title":"J. Ren. Nutr."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.metabol.2017.10.011","article-title":"Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study","volume":"79","author":"Upadhyay","year":"2018","journal-title":"Metabolism"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"e19052","DOI":"10.1097\/MD.0000000000019052","article-title":"Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus: A population-based study","volume":"99","author":"Liu","year":"2020","journal-title":"Medcine"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e31006","DOI":"10.1097\/MD.0000000000031006","article-title":"Association of serum leptin and insulin levels among type 2 diabetes mellitus patients: A case-control study","volume":"101","author":"Zhao","year":"2022","journal-title":"Medcine"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2147\/DMSO.S405476","article-title":"Association of Serum Leptin and Adiponectin Concentrations with Type 2 Diabetes Biomarkers and Complications Among Saudi Women","volume":"16","year":"2023","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/ijabmr.IJABMR_278_16","article-title":"Evaluation of Leptin as a Marker of Insulin Resistance in Type 2 Diabetes Mellitus","volume":"7","author":"Moonishaa","year":"2017","journal-title":"Int. J. Appl. Basic. Med. Res."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.25011\/cim.v45i3.38873","article-title":"Effect of Leptin Levels of Type 2 Diabetes Mellitus and Diabetic Complications","volume":"45","author":"Nan","year":"2022","journal-title":"Clin. Investig. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12933-015-0208-1","article-title":"Serum leptin levels are independently related to the incidence of ischemic heart disease in a prospective study of patients with type 2 diabetes","volume":"14","author":"Vavruch","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_174","first-page":"444","article-title":"Leptin concentrations in type 2 diabetes and non-diabetes Nigerian-Africans","volume":"10","author":"Onyemelukwe","year":"2020","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/obr.12088","article-title":"Leptin levels and risk of type 2 diabetes: Gender-specific meta-analysis","volume":"15","author":"Chen","year":"2014","journal-title":"Obes. Rev."},{"key":"ref_176","first-page":"4875799","article-title":"Effect of Gender on Serum Leptin in Type 2 Diabetes Mellitus: A System Review and Meta-Analysis","volume":"2022","author":"Li","year":"2022","journal-title":"Comput. Math. Methods Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/a-0958-2441","article-title":"Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Effect of SGLT2 Inhibitor on Blood Leptin and Adiponectin Level in Patients with Type 2 Diabetes","volume":"51","author":"Wu","year":"2019","journal-title":"Horm. Metab. Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/jdi.12783","article-title":"Effects of pioglitazone treatment on blood leptin levels in patients with type 2 diabetes","volume":"9","author":"Ida","year":"2018","journal-title":"J. Diabetes Investig."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Yoshida, T., and Delafontaine, P. (2020). Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy. Cells, 9.","DOI":"10.3390\/cells9091970"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.mad.2008.08.001","article-title":"Modulation of GH\/IGF-1 axis: Potential strategies to counteract sarcopenia in older adults","volume":"129","author":"Giovannini","year":"2008","journal-title":"Mech. Ageing Dev."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s40520-022-02180-2","article-title":"Serum IGF-1 levels are associated with sarcopenia in elderly men but not in elderly women","volume":"34","author":"Jiang","year":"2022","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3892\/etm.2016.3961","article-title":"The expression of insulin-like growth factor-1 in senior patients with diabetes and dementia","volume":"13","author":"Zhou","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/1533317519860334","article-title":"Decreased Levels of Serum IGF-1 and Vitamin D Are Associated With Cognitive Impairment in Patients with Type 2 Diabetes","volume":"34","author":"Chen","year":"2019","journal-title":"Am. J. Alzheimers Dis. Other Demen"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2362.2011.02616.x","article-title":"Interaction between glycaemic control and serum insulin-like growth factor 1 on the risk of retinopathy in type 2 diabetes","volume":"42","author":"Chen","year":"2012","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_185","first-page":"2033","article-title":"Serum GLP-1 and IGF-1 levels are candidate diagnostic biomarkers for type 2 diabetes mellitus complicated by coronary heart disease","volume":"15","author":"Wang","year":"2023","journal-title":"Am. J. Transl. Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jamda.2015.02.017","article-title":"Mail-Based Intervention for Sarcopenia Prevention Increased Anabolic Hormone and Skeletal Muscle Mass in Community-Dwelling Japanese Older Adults: The INE (Intervention by Nutrition and Exercise) Study","volume":"16","author":"Yamada","year":"2015","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/js.2018-00271","article-title":"A High Serum Cortisol\/DHEA-S Ratio Is a Risk Factor for Sarcopenia in Elderly Diabetic Patients","volume":"3","author":"Yanagita","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"bvaa050","DOI":"10.1210\/jendso\/bvaa050","article-title":"Endogenous Testosterone Levels Are Associated with Risk of Type 2 Diabetes in Women without Established Comorbidity","volume":"4","author":"Rasmussen","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jcjd.2015.09.013","article-title":"Serum Dehydroepiandrosterone Sulfate and Risk for Type 2 Diabetes in Older Men and Women: The Pro.V.A Study","volume":"40","author":"Veronese","year":"2016","journal-title":"Can. J. Diabetes"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2605.2007.00815.x","article-title":"Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction","volume":"31","author":"Sayed","year":"2008","journal-title":"Int. J. Androl."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.2337\/diacare.27.12.2893","article-title":"Association between urinary albumin excretion and serum dehydroepiandrosterone sulfate concentration in male patients with type 2 diabetes: A possible link between urinary albumin excretion and cardiovascular disease","volume":"27","author":"Fukui","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ghir.2011.07.004","article-title":"Serum insulin-like growth factor-I is negatively associated with serum adiponectin in type 2 diabetes mellitus","volume":"21","author":"Kanazawa","year":"2011","journal-title":"Growth Horm. IGF Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/jdi.13997","article-title":"Low serum dehydroepiandrosterone levels are associated with diabetic retinopathy in patients with type 2 diabetes mellitus","volume":"14","author":"Zhang","year":"2023","journal-title":"J. Diabetes Investig."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1507\/endocrj.K07E-130","article-title":"Serum DHEA-S level is associated with the presence of atherosclerosis in postmenopausal women with type 2 diabetes mellitus","volume":"55","author":"Kanazawa","year":"2008","journal-title":"Endocr. J."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2005.01.014","article-title":"Serum dehydroepiandrosterone sulfate concentration and carotid atherosclerosis in men with type 2 diabetes","volume":"181","author":"Fukui","year":"2005","journal-title":"Atherosclerosis"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"915494","DOI":"10.3389\/fendo.2022.915494","article-title":"Low Serum Dehydroepiandrosterone Is Associated With Diabetic Kidney Disease in Men With Type 2 Diabetes Mellitus","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"890029","DOI":"10.3389\/fendo.2022.890029","article-title":"Low Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate Are Associated With Coronary Heart Disease in Men With Type 2 Diabetes Mellitus","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"101185","DOI":"10.1016\/j.arr.2020.101185","article-title":"Markers of inflammation and their association with muscle strength and mass: A systematic review and meta-analysis","volume":"64","author":"Tuttle","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2021.11.005","article-title":"Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis","volume":"100","author":"Anita","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"105448","DOI":"10.1016\/j.psyneuen.2021.105448","article-title":"Depression in type 2 diabetes: A systematic review and meta-analysis of blood inflammatory markers","volume":"134","author":"Nguyen","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1177\/1060028020985303","article-title":"Effect of Metformin on Circulating Levels of Inflammatory Markers in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials","volume":"55","author":"Khadive","year":"2021","journal-title":"Ann. Pharmacother."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/10998004221132841","article-title":"Effects of Exercise Training on Inflammatory and Cardiometabolic Risk Biomarkers in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"25","author":"Hejazi","year":"2023","journal-title":"Biol. Res. Nurs."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"6660557","DOI":"10.1155\/2020\/6660557","article-title":"Effects of Exercise on Inflammatory Cytokines in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials","volume":"2020","author":"Chen","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Yang, W., Jiao, H., Xue, Y., Wang, L., Zhang, Y., Wang, B., Teng, Z., Li, J., Zhao, H., and Liu, C. (2023). A Meta-Analysis of the Influence on Inflammatory Factors in Type 2 Diabetes among Middle-Aged and Elderly Patients by Various Exercise Modalities. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20031783"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/4\/1107\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:00:19Z","timestamp":1760104819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/4\/1107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":204,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["jcm13041107"],"URL":"https:\/\/doi.org\/10.3390\/jcm13041107","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]}}}